← Research status explorer
Peak / Growth axis
Sermorelin
Also known as: Geref
Current research status
Human Research
Extensive historical human research
Preclinical
Human Research
Overview
Sermorelin is a GHRH(1-29) fragment analogue with a long history of human research and, historically, prior US regulatory approval (as Geref) before that product was discontinued. Substantial published human data exist from that earlier era, though sermorelin is not currently marketed as an FDA-approved product.
Sources
Last reviewed: September 2026
